Siga Technologies INC Deferred Costs, Current
Siga Technologies INC (SIGA) had Deferred Costs, Current of $94.34 million as of 2018-06-30, per its 10-Q filed 2018-08-07.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredCostsCurrent · last filed 2018-08-07
- 2018-06-30: Deferred Costs, Current $94.34M.
- 2017-12-31: Deferred Costs, Current $0.00.
| Period end | Deferred Costs, Current |
|---|---|
| 2018-06-30 | $94.34M 10-Q · filed 2018-08-07 |
| 2017-12-31 | $0.00 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |